Spring direct naar de hoofdnavigatie of de inhoud
‘Investing that little extra time and effort in IP at the right moment makes your technology go further.’
Jennifer Ebner von Eschenbach

Jennifer Ebner von Eschenbach

  • Chemistry
  • Life Sciences
  • European Patent Attorney
  • Senior Associate

Jennifer Ebner von Eschenbach began her career as a European patent attorney in 1991 when she commenced her training in the Munich office of the international IP law firm of Ladas & Parry, LLP. Jennifer took over the office management from 1996-2008, during which time she was involved with the prosecution of patent applications for many multinational companies and research institutions. This provided her with an insight of IP needs covering a broad technological spectrum.

Continue reading

Since joining V.O. in 2008, Jennifer has focused on developments in the pharmaceutical and chemical sectors, including novel therapies, diagnostic tools, (bio)technological processes for the employment of renewable resources, as well as environmentally-conscious chemical processes/products, again spanning both a broad range of technologies and clients.

Jennifer has a wide practical experience in procuring and defending patents, including the filing and defense of oppositions. Through the provision of opinions on patent validity and infringement, she also has considerable experience in advising on parties’ freedom to operate.

Working experience

  • Patent Attorney, V.O. (2008-present)
  • Patent Attorney, Ladas & Parry, LLP (1991-2008): Manager of office in Munich (1996-2008)
  • Post-Doctoral Research, Inorganic Chemical Institute of the Technical University of Munich (1989-1990)

Education

  • PhD in Chemistry, University of Melbourne (1988)
  • MSc in Chemistry, University of Melbourne (1984, with honours)

Directories

  • “Chemistry expert Jennifer Ebner von Eschenbach gives added heft to the firm’s life science specialisation. Detail oriented and strategic, she delivers commercially astute and technically deft prosecution to her following. With over three decades of experience in the profession, Ebner is a smart choice for business-critical portfolios across a wide array of chemical and pharmaceutical innovations” (IAM Patent 1000, 2023)
  • Recommended Individual (IAM Patent 1000, 2023)

Publications

  • •Schmidbaur H., Ebner von Eschenbach J., Kumberger O., & Müller G., Cyclic Dinuclear Gold(I) Complexes: The Crystal Structure of Bis-µ-[(diphenylphosphino)(diphenylphosphinoselenoyl)methane]-digold(I) Bis(perchlorate), Chem. Ber., 123, 2261-2265, 1990
  • Bond A. M., Colton R., Ebner J., & Ellis S. R., Differences in Nature and Stability of Cadmium Complexes with Group 15/Group 16 Donor Ligands as Determined by Multinuclear (31P, 77Se, 113Cd) Magnetic Resonance and Electrochemical Techniques, Inorganic Chemistry, 28, 4509-4516, 1989
  • Colton R., Ebner J., & Hoskins B. F., Multinuclear Magnetic Resonance Studies of the Reactions of Bidentate Ligands with Pt(S2P{OEt}2)2. Crystal and Molecular Structure of (apeS)Pt(S2P{OEt}2)2 (ApeS = Ph2AsCH2CH2P(S)Ph2) , Inorganic Chemistry, 27, 1993-1999, 1988
  • Bond A. M., Colton R., & Ebner J., Multinuclear Magnetic Resonance (31P, 77Se, 199Hg) and Electrochemical Studies of Non-labile Mercury(II) Complexes with Group 15/Group 16 Donor Ligands, Inorganic Chemistry, 27, 1697-1702, 1988

Languages

  • German
  • English

Also see these experts

Annemiek Tepper

Annemiek Tepper

  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
Andreas Keymer

Andreas Keymer

  • European and German Patent Attorney, European Patent Litigator
  • Associate
More experts

News

Secarna: leading in antisense oligonucleotides

With a growing product portfolio, Munich-based biotech company Secarna Pharmaceuticals focuses on developing so-called antisense oligonucleotide drugs, or ASOs. These drugs are used, for example, within immunoncology and in the treatment of inflammation and fibrosis. In addition, Secarna is working with partners to develop ASOs for numerous other medical applications.Continue reading

Enforcement of intellectual property rights

You have invested considerable time, energy and expense in developing and protecting an invention, design, trademark or logo. At some point you discover that a third party enters the market with a method, product, design or trademark that appears to infringe on your intellectual property (IP) rights. The question is what action you can take.Continue reading

Relaxation of rules for transfer of right of priority

The right of priority is the basis of international patent protection, allowing the applicant to continue the original patent application abroad within one year while maintaining the original filing date. In recent years, an increasing number of patents have been revoked in opposition proceedings at the European Patent Office (EPO) due to an invalid transfer […]Continue reading

Events

Jobfair Vlaamse Technische Kring (VTK) 2024

Brabanthal, Brabantlaan, Leuven, België

The VTK Jobfair will take place on Thurday 14 March 2024. The Jobfair falls during an interesting time for students to find out what the business market has to offer. It is the ideal opportunity for students to get in touch with companies through VTK.

Continue reading

Graduate Jobfair Ghent 2024

Flanders Expo, Maaltekouter, Ghent, Belgium

De Graduate Jobfair Ghent 2024 is organized by the Ghent University Association.
(Almost) graduated and looking for your first challenging job? Or, looking for further education after your bachelor (BA) or master (MA)? Get to know the current job market and a wide range of further study opportunities.

Continue reading

JCI Flemish-Brabant Young Entrepreneur of the Year 2024

De Hoorn, Sluisstraat, Leuven, Belgium

JCI Flemish-Brabant Young Entrepreneur of the Year. Our society is constantly changing. And let that be precisely the goal of Junior Chamber International ("JCI"): to bring about positive changes in our society.

Continue reading